LYELL Trademark

Trademark Overview


On Tuesday, May 4, 2021, a trademark application was filed for LYELL with the United States Patent and Trademark Office. The USPTO has given the LYELL trademark a serial number of 90689664. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, April 29, 2024. This trademark is owned by Lyell Immunopharma, Inc.. The LYELL trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of pharmaceuticals

Pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes

Medical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer

Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer
lyell

General Information


Serial Number90689664
Word MarkLYELL
Filing DateTuesday, May 4, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals
Goods and ServicesPharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
Goods and ServicesMedical services; medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer
Goods and ServicesPharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, and infectious diseases; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; scientific laboratory services; medical and scientific research; scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; scientific and technological services and biological research and development, namely, research and development related to treatment of cancer

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code040
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 6, 2021
Primary Code044
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameLyell Immunopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080

Party NameLyell Immunopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, US 94080

Trademark Events


Event DateEvent Description
Friday, May 7, 2021NEW APPLICATION ENTERED
Friday, October 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 14, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 13, 2021ASSIGNED TO EXAMINER
Thursday, October 14, 2021NON-FINAL ACTION WRITTEN
Thursday, October 14, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 18, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 18, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 19, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 14, 2022SOU EXTENSION 1 FILED
Friday, October 14, 2022SOU EXTENSION 1 GRANTED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU EXTENSION 4 FILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 4 GRANTED
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 14, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 14, 2023SOU EXTENSION 2 FILED
Friday, April 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, April 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 30, 2023SOU EXTENSION 3 FILED
Monday, October 30, 2023SOU EXTENSION 3 GRANTED